Document Detail

Topical steroid therapy in oral lichen planus: review of a novel delivery method in 24 patients.
MedLine Citation:
PMID:  9011365     Owner:  NLM     Status:  MEDLINE    
Lichen planus is a chronic mucocutaneous disorder of unknown etiology. The natural progression of oral lichen planus (OLP) is long and can extend over a number of years. Although many patients with OLP remain asymptomatic, some experience periods of marked inflammation with breakdown of the lesions, and require treatment. Corticosteroids are the mainstay of treatment for oral lesions, but delivery to affected mucosal sites can be problematic. The purpose of this study was to retrospectively review the results of topical steroid therapy in a group of patients with OLP, using a novel delivery method. The records of 33 patients with biopsy-proven OLP were reviewed and the relevant clinical features were noted at minimum review intervals of one, six and 12 months. Of this group, 24 patients had been treated using a standardized treatment protocol consisting of a corticosteroid ointment applied topically to mucosal lesions using cloth strips. Gingival lesions were treated using a steroid preparation in an adhesive paste. Nine patients remained asymptomatic and were not treated. In the treated group, 14/24 (58 per cent) of patients showed an improvement in symptoms by one month. The remainder showed no change or a worsening of their symptoms. Repetition of the treatment protocol resulted in improvement in all the non-responders, and by one year 23 of 24 (96 per cent) of the patients had experienced improvement or control of their symptoms. Long-term failure to control the symptoms in the single non-responding case was related to poor patient compliance. Results from this study show that a novel delivery method and treatment protocol for the application of topical steroids onto lesional mucosa is useful for the symptomatic control of oral lichen planus.
A Aleinikov; R C Jordan; J H Main
Related Documents :
22545885 - Current evidence is insufficient to define an optimal threshold for intervention in iso...
22315705 - Asymptomatic and symptomatic carotid stenosis: an obsolete classification?
10928765 - Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease tr...
1470285 - Effectiveness of low dose cyclosporine in acquired aplastic anaemia with severe neutrop...
24905665 - Mitraclip for severe symptomatic mitral regurgitation in patients at high surgical risk...
23347085 - Treatment of sirolimus-eluting stent restenosis: additional stent, balloon angioplasty,...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal (Canadian Dental Association)     Volume:  62     ISSN:  0709-8936     ISO Abbreviation:  J Can Dent Assoc     Publication Date:  1996 Apr 
Date Detail:
Created Date:  1997-02-04     Completed Date:  1997-02-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7907605     Medline TA:  J Can Dent Assoc     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  324-7     Citation Subset:  D; IM    
Department of dentistry, University of Toronto, Ont.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Topical
Anti-Inflammatory Agents / administration & dosage,  therapeutic use*
Betamethasone / administration & dosage,  therapeutic use*
Follow-Up Studies
Lichen Planus, Oral / drug therapy*
Middle Aged
Occlusive Dressings
Remission Induction
Retrospective Studies
Triamcinolone Acetonide / administration & dosage,  therapeutic use
Reg. No./Substance:
0/Adhesives; 0/Anti-Inflammatory Agents; 0/Glucocorticoids; 0/Ointments; 378-44-9/Betamethasone; 76-25-5/Triamcinolone Acetonide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Periodontal manifestations of systemic diseases and their management.
Next Document:  Risk assessment in dentistry: health risks of dental amalgam revisited.